Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials

BACKGROUND: A ring-shaped, contraceptive vaginal system designed to last 1 year (13 cycles) delivers an average of 0·15 mg segesterone acetate and 0·013 mg ethinylestradiol per day. We evaluated the efficacy of this contraceptive vaginal system and return to menses or pregnancy after use. METHODS: I...

Descripción completa

Detalles Bibliográficos
Autores principales: Archer, David F, Merkatz, Ruth B, Bahamondes, Luis, Westhoff, Carolyn L, Darney, Philip, Apter, Dan, Jensen, Jeffrey T, Brache, Vivian, Nelson, Anita L, Banks, Erika, Bártfai, György, Portman, David J, Plagianos, Marlena, Dart, Clint, Kumar, Narender, Creasy, George W, Sitruk-Ware, Regine, Blithe, Diana L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624423/
https://www.ncbi.nlm.nih.gov/pubmed/31231065
http://dx.doi.org/10.1016/S2214-109X(19)30265-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624423/
https://www.ncbi.nlm.nih.gov/pubmed/31231065
http://dx.doi.org/10.1016/S2214-109X(19)30265-7

Ejemplares similares